FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
Despite significant decline in heart attacks since 2004, inequities in STEMI management and mortality by age, gender, income and race, speakers reported.Two studies, one evaluating…
Decision-makers find application of GRADE-CERQual in qualitative evidence syntheses helpful as the assessments provide an indication as to how much confidence to place in synthesised…
Your access to the latest cardiovascular news, science, tools and resources.
AbstractAims. Myocardial response to stress echocardiography may be elicited physiologically, through exercise, or pharmacologically, often with dobutamine
Either intervention alone improved health in a small trial, but the best results occurred when the two were used together.
The American College of Cardiology, a 49,000-member nonprofit medical society, is dedicated to enhancing the lives of cardiovascular patients through continuous quality improvement, patient-centered care,…
Objective The management of blood pressure (BP) in acute ischaemic stroke remains a subject of controversy. This investigation aimed to explore the relationship between 24-hour…
The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets with statins, yielded superior outcomes compared to…
With the approval of mavacamten, patients with hypertrophic cardiomyopathy now have more options, Steve Ommen says.